Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hugo M Horlings

Showing results (21-30 of 103) with videos related to

Pageof 11
Sort By:
NPJ Breast Cancer|May 13, 2023
Immune landscape of breast tumors with low and intermediate estrogen receptor expressionLeonie Voorwerk, Joyce Sanders, Milou S Keusters, et al.
Gynecologic Oncology|July 2, 2014
Development and internal validation of a prognostic model to predict recurrence free survival in patients with adult granulosa cell tumors of the ovaryHannah S van Meurs, Ewoud Schuit, Hugo M Horlings, et al.
Breast Cancer Research : BCR|December 23, 2008
EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancerAlexandra M Pietersen, Hugo M Horlings, Michael Hauptmann, et al.
Cell Reports. Medicine|July 25, 2023
RadioLOGIC, a healthcare model for processing electronic health records and decision-making in breast diseaseTianyu Zhang, Tao Tan, Xin Wang, et al.
Breast Cancer Research and Treatment|October 29, 2013
Genomic profiling of histological special types of breast cancerHugo M Horlings, Britta Weigelt, Eric M Anderson, et al.
Genes & Development|May 3, 2012
Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesisLiesbeth C W Vredeveld, Patricia A Possik, Marjon A Smit, et al.
International Journal of Cancer|August 2, 2014
Sorafenib synergizes with metformin in NSCLC through AMPK pathway activationFloris H Groenendijk, Wouter W Mellema, Eline van der Burg, et al.
Nature Communications|October 27, 2011
Selective inhibition of microRNA accessibility by RBM38 is required for p53 activityNicolas Léveillé, Ran Elkon, Veronica Davalos, et al.
NPJ Breast Cancer|March 23, 2023
Predicting breast cancer types on and beyond molecular level in a multi-modal fashionTianyu Zhang, Tao Tan, Luyi Han, et al.
Oncotarget|August 25, 2016
Identification of breast cancer cell subtypes sensitive to ATG4B inhibitionSvetlana Bortnik, Courtney Choutka, Hugo M Horlings, et al.
Pageof 11

Showing results (21-30 of 103) with videos related to

Sort By:
Pageof 11
NPJ Breast Cancer|May 13, 2023
Immune landscape of breast tumors with low and intermediate estrogen receptor expressionLeonie Voorwerk, Joyce Sanders, Milou S Keusters, et al.
Gynecologic Oncology|July 2, 2014
Development and internal validation of a prognostic model to predict recurrence free survival in patients with adult granulosa cell tumors of the ovaryHannah S van Meurs, Ewoud Schuit, Hugo M Horlings, et al.
Breast Cancer Research : BCR|December 23, 2008
EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancerAlexandra M Pietersen, Hugo M Horlings, Michael Hauptmann, et al.
Cell Reports. Medicine|July 25, 2023
RadioLOGIC, a healthcare model for processing electronic health records and decision-making in breast diseaseTianyu Zhang, Tao Tan, Xin Wang, et al.
Breast Cancer Research and Treatment|October 29, 2013
Genomic profiling of histological special types of breast cancerHugo M Horlings, Britta Weigelt, Eric M Anderson, et al.
Genes & Development|May 3, 2012
Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesisLiesbeth C W Vredeveld, Patricia A Possik, Marjon A Smit, et al.
International Journal of Cancer|August 2, 2014
Sorafenib synergizes with metformin in NSCLC through AMPK pathway activationFloris H Groenendijk, Wouter W Mellema, Eline van der Burg, et al.
Nature Communications|October 27, 2011
Selective inhibition of microRNA accessibility by RBM38 is required for p53 activityNicolas Léveillé, Ran Elkon, Veronica Davalos, et al.
NPJ Breast Cancer|March 23, 2023
Predicting breast cancer types on and beyond molecular level in a multi-modal fashionTianyu Zhang, Tao Tan, Luyi Han, et al.
Oncotarget|August 25, 2016
Identification of breast cancer cell subtypes sensitive to ATG4B inhibitionSvetlana Bortnik, Courtney Choutka, Hugo M Horlings, et al.
Pageof 11